Deep Health AI

  • Market Cap: Micro Cap
  • Industry: Gems, Jewellery And Watches
  • ISIN: INE005G01026
  • NSEID:
  • BSEID: 539559
INR
2.21
0.1 (4.74%)
BSENSE

Jun 30, 02:21 PM

BSE+NSE Vol: 6.97 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

6.97 lacs (137.33%) Volume

Shareholding (Mar 2026)

FII

0.35%

Held by 1 FIIs

DII

0.00%

Held by 0 DIIs

Promoter

0.03%

Why is Deep Health AI India Ltd falling/rising?

29-Jun-2026

As of 29-Jun, Deep Health AI India Ltd's stock price is declining, currently at 2.11, reflecting a significant underperformance with a year-to-date drop of -64.12%. Despite recent positive quarterly results, weak long-term fundamentals and bearish trading signals contribute to the negative investor sentiment.

As of 29-Jun, Deep Health AI India Ltd's stock price is falling, currently at 2.11, which reflects a change of -0.04 or -1.86%. The stock has been underperforming significantly, with a consecutive decline over the last four days, resulting in a total drop of -6.61% during this period. This trend is further supported by the stock's performance over various time frames, showing a year-to-date decline of -64.12% and a one-year drop of -50.73%, both of which indicate consistent underperformance against the benchmark, the Sensex.<BR><BR>Additionally, the stock is trading below its moving averages across multiple time frames, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, which typically signals a bearish trend. Investor participation has also decreased, as evidenced by a 34.03% drop in delivery volume compared to the 5-day average. <BR><BR>While the company has reported positive results for the last three consecutive quarters, with a significant growth in profit after tax, the overall long-term fundamentals remain weak. The average return on equity is low at 6.14%, and the company's ability to service its debt is concerning, indicated by a poor EBIT to interest ratio of 1.00. Furthermore, despite a high dividend yield of 4.65%, the stock's valuation appears expensive relative to its peers, contributing to the negative sentiment among investors. Overall, these factors collectively explain the decline in Deep Health AI India Ltd's stock price.

View full answer

How big is Deep Health AI?

11-Jun-2026

As of 10th June, Deep Health AI India Ltd has a market capitalization of 30.00 Cr, with recent net sales of 4.25 Cr and net profit of 1.12 Cr over the last four quarters.

As of 10th June, <BR><BR>Market Cap: Deep Health AI India Ltd has a market capitalization of 30.00 Cr, categorizing it as a Micro Cap company.<BR><BR>Recent Quarterly Performance: The sum of Net Sales for the latest 4 quarters is 4.25 Cr, while the sum of Net Profit for the same period is 1.12 Cr.<BR><BR>Balance Sheet Snapshot: The reporting period for the latest annual data is March 2025. Shareholder's Funds are valued at 22.36 Cr, and Total Assets amount to 23.96 Cr.

View full answer

Who are in the management team of Deep Health AI?

11-Jun-2026

The management team of Deep Health AI includes Ganpat Lal Nyati (Executive Director), Sonali Laddha (CEO), Narendra Shrimali, Ashish Jain, and Vinod Mandowara (all Non-Executive Directors), Prashant Tali (Company Secretary), and Kaushal Jain (Additional Director). They are responsible for the company's strategic direction and operations.

The management team of Deep Health AI includes the following individuals:<BR><BR>1. **Ganpat Lal Nyati** - Executive Director & Wholetime Director<BR>2. **Sonali Laddha** - Executive Director & CEO<BR>3. **Narendra Shrimali** - Non-Executive & Non-Independent Director<BR>4. **Ashish Jain** - Non-Executive & Non-Independent Director<BR>5. **Vinod Mandowara** - Non-Executive & Non-Independent Director<BR>6. **Prashant Tali** - Company Secretary & Compliance Officer<BR>7. **Kaushal Jain** - Additional Director<BR><BR>This team plays a crucial role in guiding the company’s strategic direction and operations.

View full answer

Who are the peers of the Deep Health AI?

11-Jun-2026

Deep Health AI's peers include U. H. Zaveri, Manoj Jewellers, and several others, with varying management risks and growth rates. U. H. Zaveri has the highest 1-year return at 138.77%, while Deep Health AI has the lowest at -54.16%.

Peers: The peers of Deep Health AI are U. H. Zaveri, Sarup Industries, Manoj Jewellers, Shoora Designs, Kanani Industrie, Kenvi Jewels, Orosil Smiths, Goenka Diamond, S K Internation, and Shubhlaxmi Jewel.<BR><BR>Quality Snapshot: Excellent management risk is observed at Manoj Jewellers, while Good management risk is found at Deep Health AI. Below Average management risk is noted at U. H. Zaveri, Shoora Designs, Kanani Industrie, Kenvi Jewels, Goenka Diamond, S K Internation, and Shubhlaxmi Jewel, and the rest. Growth is Excellent at Manoj Jewellers, Good at Deep Health AI, and Below Average at U. H. Zaveri, Shoora Designs, Kanani Industrie, Kenvi Jewels, Orosil Smiths, Goenka Diamond, S K Internation, and Shubhlaxmi Jewel, and the rest. Average capital structure is seen at Manoj Jewellers, Good at Deep Health AI, and Below Average at U. H. Zaveri, Shoora Designs, Kanani Industrie, Kenvi Jewels, Orosil Smiths, Goenka Diamond, S K Internation, and Shubhlaxmi Jewel, and the rest.<BR><BR>Return Snapshot: The peer with the highest 1-year return is U. H. Zaveri at 138.77%, while the peer with the lowest is Deep Health AI at -54.16%. Deep Health AI's 1-year return is significantly lower than that of U. H. Zaveri. Additionally, peers with negative six-month returns include Deep Health AI, Kanani Industrie, Kenvi Jewels, Goenka Diamond, and Orosil Smiths.

View full answer

What does Deep Health AI do?

10-Jun-2026

Deep Health AI India Ltd manufactures and wholesales gold set jewellery with diamonds and offers consultancy services to the Pharmaceutical Industry. As of March 2026, the company reported net sales of 0 Cr and a net profit of -5 Cr, with a market cap of INR 30 Cr.

Overview: <BR>Deep Health AI India Ltd operates in the Gems, Jewellery and Watches industry, focusing on the manufacture and wholesale of gold set jewellery with diamonds, as well as providing consultancy services to the Pharmaceutical Industry.<BR><BR>History: <BR>Deep Health AI India Ltd was established in 1994. The company has recently expanded its business to include consultancy services for the Pharmaceutical Industry. The latest quarterly results reported are for March 2026, showing net sales and profit figures.<BR><BR>Financial Snapshot: <BR>Most recent Net Sales: 0 Cr (Quarterly Results - Mar 2026) <BR>Most recent Net Profit: -5 Cr (Quarterly Results - Mar 2026) <BR>Market-cap value: INR 30 Cr (Micro Cap)<BR><BR>Key Metrics: <BR>P/E: 4.00 <BR>Industry P/E: 45 <BR>Dividend Yield: 4.76% <BR>Debt-Equity: -0.17 <BR>Return on Equity: 13.41% <BR>Price to Book: 0.59 <BR><BR>Contact Details: <BR>Address: 101 1st Floor Hemu Plaza, D J Road Vile Parle (W) Mumbai Maharashtra : 400056 <BR>Tel: 91-22-26174321/65043314 <BR>Website: http://www.deepdiamondindialimited.com

View full answer

Should I buy, sell or hold Deep Health AI India Ltd?

28-May-2026

Are Deep Diamond India Ltd latest results good or bad?

12-Feb-2026

The latest results for Deep Diamond India Ltd are concerning, as a reported net profit of ₹3.04 crore is misleading due to heavy reliance on non-operating income, while net sales fell dramatically by 85.07% to ₹0.50 crore, indicating significant operational challenges. Overall, the results suggest a struggling business rather than a healthy one.

The latest results for Deep Diamond India Ltd present a mixed picture, highlighting significant operational challenges despite a seemingly positive net profit figure. In Q3 FY26, the company reported a consolidated net profit of ₹3.04 crore, which is a substantial increase of 20.16% quarter-on-quarter. However, this profit growth is largely misleading due to the company's heavy reliance on non-operating income, which constituted 101.37% of profit before tax.<BR><BR>On the downside, net sales plummeted to ₹0.50 crore, representing a dramatic 85.07% decline from the previous quarter. This sharp drop in revenue raises serious concerns about the sustainability of the company's core business operations. The operating margin, excluding other income, fell significantly to 20.0%, down from 96.42% in the previous quarter, indicating severe operational distress.<BR><BR>Overall, while the profit figure may appear favorable at first glance, the underlying fundamentals reveal a company struggling with revenue generation and operational efficiency. The reliance on non-operating income and the substantial decline in sales suggest that the results are more indicative of a troubled business than a healthy one. Therefore, the latest results can be considered bad, reflecting deep-seated issues within the company's operational model.

View full answer

How has been the historical performance of Deep Diamond?

02-Dec-2025

Deep Diamond has experienced a significant decline in net sales over three years, dropping from 7.67 Cr in Mar'23 to 1.26 Cr in Mar'25, while improving profitability metrics such as operating profit and profit before tax in the latest year. Total liabilities and assets increased slightly, and shareholder's funds strengthened, indicating a challenging environment with some recovery in profitability.

Answer:<BR>The historical performance of Deep Diamond shows a significant decline in net sales over the past three years, dropping from 7.67 Cr in Mar'23 to 2.56 Cr in Mar'24, and further down to 1.26 Cr in Mar'25. Total operating income followed a similar trend, decreasing from 7.67 Cr in Mar'23 to 2.56 Cr in Mar'24, and then to 1.26 Cr in Mar'25. Despite the decline in sales, the company managed to improve its operating profit (PBDIT) from 1.85 Cr in Mar'23 to 0.84 Cr in Mar'24, and further to 1.20 Cr in Mar'25. Profit before tax also increased from 1.73 Cr in Mar'23 to 0.57 Cr in Mar'24, reaching 1.09 Cr in Mar'25. The profit after tax showed a similar pattern, with values of 1.26 Cr, 0.42 Cr, and 0.86 Cr for the respective years. The earnings per share (EPS) decreased from 0.26 in Mar'23 to 0.08 in Mar'24, but increased to 0.17 in Mar'25. <BR><BR>In terms of balance sheet results, total liabilities rose slightly from 23.06 Cr in Mar'24 to 23.96 Cr in Mar'25, while total assets also increased from 23.06 Cr to 23.96 Cr in the same period. Shareholder's funds improved from 20.42 Cr in Mar'24 to 22.36 Cr in Mar'25, indicating a strengthening equity position. The cash flow from operating activities remained stagnant at 0.00 Cr in Mar'25, while it was negative at -5.00 Cr in Mar'24. The closing cash and cash equivalents remained unchanged at 3.00 Cr for both years. Overall, Deep Diamond's financial performance reflects a challenging environment with declining sales but some recovery in profitability metrics in the latest year.

View full answer

Is Deep Diamond overvalued or undervalued?

09-Jun-2025

As of May 30, 2025, Deep Diamond is considered very expensive and overvalued, with a PE ratio of 15.01, an EV to EBIT of 12.30, and a disappointing year-to-date return of -30.99%, especially compared to its peers and the Sensex's positive return of 5.61%.

As of 30 May 2025, the valuation grade for Deep Diamond has moved from risky to very expensive. This indicates a significant shift in the perception of the company's value, suggesting that it is currently overvalued. The key ratios reflect this sentiment, with a PE ratio of 15.01, an EV to EBIT of 12.30, and a ROE of 3.94%. <BR><BR>In comparison to its peers, Deep Diamond's valuation stands out unfavorably; for instance, Titan Company has a PE ratio of 94.61 and Kalyan Jewellers at 81.3, both indicating a more robust market position despite their higher valuations. The company's recent stock performance has also been underwhelming, with a year-to-date return of -30.99%, contrasting sharply with the Sensex's positive return of 5.61% over the same period. Overall, Deep Diamond appears to be overvalued in the current market context.

View full answer

What is the technical trend for Deep Diamond?

09-Jun-2025

As of June 5, 2025, Deep Diamond's trend is mildly bearish, with daily moving averages indicating a bearish outlook, while weekly indicators show mixed signals, leading to an overall weak trend.

As of 5 June 2025, the technical trend for Deep Diamond has changed from bearish to mildly bearish. The current stance is mildly bearish, driven by the daily moving averages indicating a mildly bearish outlook, while the weekly MACD shows a mildly bullish signal, contrasting with the monthly MACD which remains bearish. The Bollinger Bands are bearish on both weekly and monthly time frames, and the KST indicates a mildly bullish trend weekly but mildly bearish monthly. Overall, the lack of strong signals from the RSI and Dow Theory suggests a weak trend in both weekly and monthly perspectives.

View full answer

Who are the top shareholders of the Deep Diamond?

06-Jun-2025

The top shareholders of Deep Diamond are primarily individual investors, holding 89.27% of shares. Notable shareholders include Bhavishya Ecommerce Private Limited at 3.55%, and Prakash Rikhabchand Solanki, the main promoter, with 0.02%.

The top shareholders of Deep Diamond include individual investors, who hold a significant 89.27% of the shares. Among the notable public shareholders, Bhavishya Ecommerce Private Limited holds 3.55%. The promoter with the highest holding is Prakash Rikhabchand Solanki, with a stake of 0.02%. Additionally, there is one Foreign Institutional Investor (FII) that holds 1.04% of the shares. There are no pledged promoter holdings or mutual fund schemes involved in the shareholding structure.

View full answer

When is the next results date for Deep Diamond?

06-Jun-2025

No Upcoming Board Meetings

Has Deep Diamond declared dividend?

06-Jun-2025

No Dividend History Available

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Dashboard

1

Weak Long Term Fundamental Strength with an average Return on Equity (ROE) of 6.14%

  • Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of 1.00
2

With ROE of 13.4, it has a Expensive valuation with a 0.6 Price to Book Value

3

Consistent Underperformance against the benchmark over the last 3 years

stock-summaryMojo Parameters

Mojo Parameters

Loading Valuation Snapshot...

Stock DNA

stock-summary
Industry

Gems, Jewellery And Watches

stock-summary
Market cap

INR 32 Cr (Micro Cap)

stock-summary
P/E

4.00

stock-summary
Industry P/E

47

stock-summary
Dividend Yield

4.72%

stock-summary
Debt Equity

-0.17

stock-summary
Return on Equity

13.41%

stock-summary
Price to Book

0.59

Revenue and Profits:
Net Sales:
0 Cr
(Quarterly Results - Mar 2026)
Net Profit:
-5 Cr
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (4.72%)
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
16.32%
0%
16.32%
6 Months
-64.24%
0%
-64.24%
1 Year
-48.62%
2.24%
-46.38%
2 Years
-61.1%
1.79%
-59.31%
3 Years
-73.99%
1.58%
-72.41%
4 Years
18.79%
2.62%
21.41%
5 Years
0%
8.85%
8.85%

Latest dividend: 0.1 per share ex-dividend date: Nov-07-2025

Risk Adjusted Returns v/s stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryNews & Corporate Actions

Announcements stock-summary

Closure of Trading Window

26-Jun-2026 | Source : BSE

Respected Sir/Madam Pursuant to Securities and Exchange Board of Indi(Prohibition of Insider Trading) (Amendment) Regulations 2015 read with SEBI (Prohibition of Insider Trading)(Amendment)Regulations 2018 including the Second Amendment in the said Regulations dated July 25 2019 we wish to inform you that the Trading Window for dealing in equity shares of the Company shall remain closed from trading hours of July 01 2026 till 48 hours after the declaration of Un-Audited Financial Results for the Quarter ended June 30 2026 for all the Designated Persons and their Immediate Relatives.

Announcement under Regulation 30 (LODR)-Acquisition

25-Jun-2026 | Source : BSE

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 (SEBI Listing Regulations) we wish to inform that the Company has made acquisition of 06.37% each of the paid-up equity share capital of Leapfrog Engineering Services Ltd. the details of which are mentioned below in Annexure A respectively. We enclose herewith the details required under Regulation 30 of SEBI Listing Regulations and 1 of Para A of Part A of the Schedule III of the aforesaid regulation read with SEBI Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30 2026 in Annexure to this letter.

Announcement under Regulation 30 (LODR)-Newspaper Publication

31-May-2026 | Source : BSE

Pursuant to Regulations 33 and 47 read with Schedule III of SEBI (Listing Obligations and Disclosures Requirements) Regulations 2015 please find enclosed a copy of the newspaper publication dated May 31 2026 in the following newspapers with respect to Audited Standalone and Consolidated Financial Results for the Quarter and Financial Year ended March 31 2026 approved at the meeting of Board of Directors held on Friday May 29 2026: 1. Prabhat Headline in English Language 2. Prabhat Abhinandan in Hindi Language

Corporate Actions stock-summary

stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

Deep Health AI India Ltd has declared 10% dividend, ex-date: 07 Nov 25

stock-summary
SPLITS

Deep Health AI India Ltd has announced 1:10 stock split, ex-date: 20 Jan 23

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

Deep Health AI India Ltd has announced 2:1 rights issue, ex-date: 29 Aug 25

stock-summaryKey Factors

Quality key factors stock-summary

Factor
Value
Sales Growth (5y)
36.51%
EBIT Growth (5y)
35.57%
EBIT to Interest (avg)
1.00
Debt to EBITDA (avg)
0.70
Net Debt to Equity (avg)
-0.17
Sales to Capital Employed (avg)
0.17
Tax Ratio
28.75%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0.35%
ROCE (avg)
3.05%
ROE (avg)
6.14%

Valuation key factors

Factor
Value
P/E Ratio
4
Industry P/E
47
Price to Book Value
0.59
EV to EBIT
6.53
EV to EBITDA
6.53
EV to Capital Employed
0.51
EV to Sales
5.11
PEG Ratio
0.05
Dividend Yield
4.72%
ROCE (Latest)
7.83%
ROE (Latest)
13.41%

Technicals key factors

Indicator
Weekly
Monthly
MACD
Mildly Bullish
Bearish
RSI
Bearish
Bearish
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Mildly Bullish
Bearish
Dow Theory
Mildly Bullish
Mildly Bullish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Mar 2026stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Non Institution

Pledged Promoter Holdings

None

Mutual Funds

Held by 0 Schemes

FIIs

Held by 1 FIIs (0.35%)

Promoter with highest holding

Prakash Rikhabchand Solanki (0.01%)

Highest Public shareholder

Vicky Rajesh Jhaveri (2.06%)

Individual Investors Holdings

94.51%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Mar'26 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Mar 2026 is -44.44% vs -73.53% in Mar 2025",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Mar 2026 is -1,388.57% vs 369.23% in Mar 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.25",
          "val2": "0.45",
          "chgp": "-44.44%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "0.05",
          "val2": "0.23",
          "chgp": "-78.26%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.01",
          "val2": "0.03",
          "chgp": "-66.67%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-5.77",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-4.51",
          "val2": "0.35",
          "chgp": "-1,388.57%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "20.00%",
          "val2": "51.11%",
          "chgp": "-31.11%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Consolidated) - Sep'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": " Growth in half year ended Sep 2025 is 332.10% vs -31.93% in Sep 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": " Growth in half year ended Sep 2025 is 430.61% vs 372.22% in Sep 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Sep'25",
        "Sep'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "3.50",
          "val2": "0.81",
          "chgp": "332.10%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "3.18",
          "val2": "0.37",
          "chgp": "759.46%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.01",
          "val2": "0.05",
          "chgp": "-80.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "2.60",
          "val2": "0.49",
          "chgp": "430.61%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "90.86%",
          "val2": "45.68%",
          "chgp": "45.18%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "header": "Nine Monthly Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in nine months ended Dec 2025 is 393.83% vs -60.49% in Dec 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in nine months ended Dec 2025 is 964.15% vs 51.43% in Dec 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "4.00",
          "val2": "0.81",
          "chgp": "393.83%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "3.28",
          "val2": "0.22",
          "chgp": "1,390.91%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.02",
          "val2": "0.06",
          "chgp": "-66.67%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "5.64",
          "val2": "0.53",
          "chgp": "964.15%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "82.00%",
          "val2": "27.16%",
          "chgp": "54.84%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Mar'26",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2026 is 237.30% vs -50.78% in Mar 2025",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2026 is 28.41% vs 120.00% in Mar 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "4.25",
          "val2": "1.26",
          "chgp": "237.30%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "3.34",
          "val2": "0.45",
          "chgp": "642.22%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.03",
          "val2": "0.09",
          "chgp": "-66.67%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-5.77",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "1.13",
          "val2": "0.88",
          "chgp": "28.41%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "78.59%",
          "val2": "35.71%",
          "chgp": "42.88%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Mar'26 - YoYstock-summary

Mar'26
Mar'25
Change(%)
Net Sales
0.25
0.45
-44.44%
Operating Profit (PBDIT) excl Other Income
0.05
0.23
-78.26%
Interest
0.01
0.03
-66.67%
Exceptional Items
-5.77
0.00
Consolidate Net Profit
-4.51
0.35
-1,388.57%
Operating Profit Margin (Excl OI)
20.00%
51.11%
-31.11%
Values in Rs Cr.
Direction Arrows
Net Sales

YoY Growth in quarter ended Mar 2026 is -44.44% vs -73.53% in Mar 2025

Direction Arrows
Consolidated Net Profit

YoY Growth in quarter ended Mar 2026 is -1,388.57% vs 369.23% in Mar 2025

Half Yearly Results Snapshot (Consolidated) - Sep'25stock-summary

Sep'25
Sep'24
Change(%)
Net Sales
3.50
0.81
332.10%
Operating Profit (PBDIT) excl Other Income
3.18
0.37
759.46%
Interest
0.01
0.05
-80.00%
Exceptional Items
0.00
0.00
Consolidate Net Profit
2.60
0.49
430.61%
Operating Profit Margin (Excl OI)
90.86%
45.68%
45.18%
Values in Rs Cr.
Direction Arrows
Net Sales

Growth in half year ended Sep 2025 is 332.10% vs -31.93% in Sep 2024

Direction Arrows
Consolidated Net Profit

Growth in half year ended Sep 2025 is 430.61% vs 372.22% in Sep 2024

Nine Monthly Results Snapshot (Consolidated) - Dec'25stock-summary

Dec'25
Dec'24
Change(%)
Net Sales
4.00
0.81
393.83%
Operating Profit (PBDIT) excl Other Income
3.28
0.22
1,390.91%
Interest
0.02
0.06
-66.67%
Exceptional Items
0.00
0.00
Consolidate Net Profit
5.64
0.53
964.15%
Operating Profit Margin (Excl OI)
82.00%
27.16%
54.84%
Values in Rs Cr.
Direction Arrows
Net Sales

YoY Growth in nine months ended Dec 2025 is 393.83% vs -60.49% in Dec 2024

Direction Arrows
Consolidated Net Profit

YoY Growth in nine months ended Dec 2025 is 964.15% vs 51.43% in Dec 2024

Annual Results Snapshot (Consolidated) - Mar'26stock-summary

Mar'26
Mar'25
Change(%)
Net Sales
4.25
1.26
237.30%
Operating Profit (PBDIT) excl Other Income
3.34
0.45
642.22%
Interest
0.03
0.09
-66.67%
Exceptional Items
-5.77
0.00
Consolidate Net Profit
1.13
0.88
28.41%
Operating Profit Margin (Excl OI)
78.59%
35.71%
42.88%
Values in Rs Cr.
Direction Arrows
Net Sales

YoY Growth in year ended Mar 2026 is 237.30% vs -50.78% in Mar 2025

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Mar 2026 is 28.41% vs 120.00% in Mar 2025

stock-summaryCompany CV
About Deep Health AI India Ltd stock-summary
stock-summary
Deep Health AI India Ltd
Micro Cap
Gems, Jewellery And Watches
Deep Diamond India Limited was established in 1994, with the object to engaged in the manufacture and wholesale of gold set jewellery with diamonds. The company also deals in loose diamonds, solitaires, and gold frames. It offers Pendants, Nose pins, Rings, Bangles, Earrings, Pendant sets, Necklace sets, Bracelets, and others. From financial year 2022-23, the Company has also started business of providing consultancy service to Pharmaceutical Industry.
Company Coordinates stock-summary
Company Details
101 1st Floor Hemu Plaza, D J Road Vile Parle (W) Mumbai Maharashtra : 400056
stock-summary
Tel: 91-22-26174321/65043314
stock-summary
Registrar Details
Mondkar Computers Pvt Ltd , 21 Shakil Niwas , Opp. Satya Saibaba Temple, Mahakali Caves Road, Andheri (E), Mumbai